Drug Treatment of Sleep Disorders (Paperback, Softcover reprint of the original 1st ed. 2015)

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Milestones in Drug Therapy
Release date:	August 2016
First published:	2015
Editors:	Antonio Guglietta
Dimensions:	235 x 155 x 17mm (L x W x T)
Format:	Paperback
Pages:	297
Edition:	Softcover reprint of the original 1st ed. 2015
ISBN-13:	978-3-319-37920-3
Categories:	Books > Medicine > Other branches of medicine > Psychiatry Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Nursing & ancillary services > Specific disorders & therapies > Sleep disorders Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences Promotions
LSN:	3-319-37920-8
Barcode:	9783319379203

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!